FGFR3 and neoplasm: FGFR3 was mutated in 2/17 primary tumours of patients with recurrence, and 3/18 patients without recurrence, with one mutation (Ser249Cys) accounting for 4/5 of the mutations and the remaining mutation being adjacent (Arg248Cys).